For patients with opioid use disorder taking buprenorphine-naloxone, it is deemed appropriate to continue three times-daily dosing
Screening protocol could identify candidates for neuromodulation therapies who could skip a formal in-person psychological assessment
Group-based CBT intervention produced modest, but sustained, reductions in measures of pain, pain-related disability
66 percent of patients randomly assigned to pain reprocessing therapy were pain-free after treatment compared with 20 percent in placebo group
Sleep disturbance in older adults also more common among those living with a partner and urinating at night
Virtual reality intervention also significantly decreases pain among patients undergoing peripheral IV catheter placement
Findings show noninferior outcomes at three months versus cognitive behavioral therapy
Most patients had co-occurring symptoms: 21.3, 19.1, and 17.4 percent had two, three, and four symptoms, respectively
Worse pain-related physical function, psychosocial functioning, increased health care utilization reported for chronic migraine with overlapping pain